Click the button below to see similar posts for other categories

What Are the Key Molecular Biomarkers for Early Detection of Cancer?

Understanding Cancer Detection

Finding cancer early is very important. It can help doctors give better treatment and improve how long patients live after being diagnosed. Scientists have discovered special markers in the body that can help find different types of cancer sooner. These markers can be genes, proteins, or other substances that show what’s happening in the body.

Key Molecular Markers

  1. Genetic Changes:

    • TP53: This gene is changed in about half of all cancers. If it’s mutated, it often means the cancer is more serious.
    • KRAS: Changes in the KRAS gene are found in 25% of cancers, especially in pancreatic and colorectal cancers.
    • BRCA1/BRCA2: Changes in these genes can lead to higher chances of breast and ovarian cancers. For those with a BRCA1 mutation, the chance of getting breast cancer can be as high as 87%.

  2. Circulating Tumor DNA (ctDNA):

    • This type of DNA can be found in the blood and can show if there’s a tumor, even when it’s small. It's often accurate in 70% of cases. It can also help doctors see if treatment is working or if the cancer comes back.

  3. Protein Markers:

    • Prostate-Specific Antigen (PSA): Doctors use this test for prostate cancer. It correctly identifies cancer about 60% to 70% of the time and has an 80% chance of finding cancer when it’s present.
    • Carcinoembryonic Antigen (CEA): This marker is mostly used for colorectal cancer and is about 45% accurate at a certain level.

  4. MicroRNAs (miRNAs):

    • Certain miRNAs are found more in some cancers. For example, a type called miR-21 is present in larger amounts in breast cancer tissues. Scientists are looking into using it as a way to help detect cancer.

The Impact of Early Detection

  • When cancer is found early, the chances of living for at least 5 more years are about 90%. But if it is found later on, that number drops to just 27%.
  • Using these markers to screen for cancer could lower the number of deaths by 20% to 30% for some types of cancer.

Conclusion

Knowing about these markers is key to finding cancer early. They help doctors decide on treatments and can improve how patients do overall. Ongoing research is needed to make these markers even more accurate.

Related articles

Similar Categories
General Pathology for Medical PathologySystems Pathology for Medical PathologyNeoplastic Pathology for Medical Pathology
Click HERE to see similar posts for other categories

What Are the Key Molecular Biomarkers for Early Detection of Cancer?

Understanding Cancer Detection

Finding cancer early is very important. It can help doctors give better treatment and improve how long patients live after being diagnosed. Scientists have discovered special markers in the body that can help find different types of cancer sooner. These markers can be genes, proteins, or other substances that show what’s happening in the body.

Key Molecular Markers

  1. Genetic Changes:

    • TP53: This gene is changed in about half of all cancers. If it’s mutated, it often means the cancer is more serious.
    • KRAS: Changes in the KRAS gene are found in 25% of cancers, especially in pancreatic and colorectal cancers.
    • BRCA1/BRCA2: Changes in these genes can lead to higher chances of breast and ovarian cancers. For those with a BRCA1 mutation, the chance of getting breast cancer can be as high as 87%.

  2. Circulating Tumor DNA (ctDNA):

    • This type of DNA can be found in the blood and can show if there’s a tumor, even when it’s small. It's often accurate in 70% of cases. It can also help doctors see if treatment is working or if the cancer comes back.

  3. Protein Markers:

    • Prostate-Specific Antigen (PSA): Doctors use this test for prostate cancer. It correctly identifies cancer about 60% to 70% of the time and has an 80% chance of finding cancer when it’s present.
    • Carcinoembryonic Antigen (CEA): This marker is mostly used for colorectal cancer and is about 45% accurate at a certain level.

  4. MicroRNAs (miRNAs):

    • Certain miRNAs are found more in some cancers. For example, a type called miR-21 is present in larger amounts in breast cancer tissues. Scientists are looking into using it as a way to help detect cancer.

The Impact of Early Detection

  • When cancer is found early, the chances of living for at least 5 more years are about 90%. But if it is found later on, that number drops to just 27%.
  • Using these markers to screen for cancer could lower the number of deaths by 20% to 30% for some types of cancer.

Conclusion

Knowing about these markers is key to finding cancer early. They help doctors decide on treatments and can improve how patients do overall. Ongoing research is needed to make these markers even more accurate.

Related articles